MGO One Seven LLC Invests $704,000 in Agilent Technologies, Inc. $A

MGO One Seven LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,484 shares of the medical research company’s stock, valued at approximately $704,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Capital A Wealth Management LLC raised its holdings in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares in the last quarter. Davis Capital Management purchased a new stake in Agilent Technologies in the third quarter valued at approximately $28,000. State of Wyoming purchased a new stake in Agilent Technologies in the second quarter valued at approximately $35,000. SJS Investment Consulting Inc. lifted its position in Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 312 shares during the last quarter. Finally, Salomon & Ludwin LLC grew its stake in Agilent Technologies by 242.5% in the 3rd quarter. Salomon & Ludwin LLC now owns 363 shares of the medical research company’s stock worth $51,000 after buying an additional 257 shares in the last quarter.

Agilent Technologies Stock Down 3.6%

Shares of NYSE:A opened at $139.68 on Friday. The stock has a market capitalization of $39.60 billion, a P/E ratio of 30.56, a price-to-earnings-growth ratio of 4.20 and a beta of 1.29. The stock’s 50-day moving average price is $144.41 and its 200-day moving average price is $133.36. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $160.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same period in the prior year, the business posted $1.46 EPS. Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a $0.255 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. This trade represents a 27.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 16,401 shares of company stock worth $2,468,962.

Analyst Ratings Changes

Several research firms have recently weighed in on A. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. UBS Group increased their target price on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Morgan Stanley assumed coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They set an “overweight” rating for the company. Bank of America upped their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $163.31.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.